TYLER HYSLEP: Open Payments
NPI 1265822720 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,807 in 146 payments from 32 companies in 2025. Trend: 2023 $2,777 · 2024 $2,962 · 2025 $2,807
Food & beverage: $2,807
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $418 |
| Novo Nordisk Inc | 20 | $385 |
| ABBVIE INC. | 16 | $300 |
| Amgen Inc. | 15 | $193 |
| AstraZeneca Pharmaceuticals LP | 6 | $144 |
| Astellas Pharma US Inc | 6 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $110 |
| Bausch Health US, LLC | 5 | $96 |
| Lilly USA, LLC | 5 | $95 |
| Axsome Therapeutics, Inc. | 5 | $89 |
Products named: NURTEC ODT, PREVNAR 20, Veozah, Ozempic, Rybelsus, JARDIANCE, Wegovy, APLENZIN.
Industry payments across NC — which companies pay providers there.
